わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/02/08 | 日証協 | 111,921株 | +32.11% | 47,012株 | -61.66% | 231,034株 | +34.22% | 28,200株 | -66.71% |
2019/02/01 | 日証協 | 84,721株 | +17% | 122,612株 | +294.14% | 172,134株 | +9.69% | 84,700株 | +197.19% |
2019/01/25 | 日証協 | 72,412株 | +13.83% | 31,109株 | +36.44% | 156,934株 | +11.2% | 28,500株 | +54.05% |
2019/01/18 | 日証協 | 63,612株 | -8.22% | 22,800株 | -18.31% | 141,134株 | -13.49% | 18,500株 | -11.9% |
2019/01/11 | 日証協 | 69,312株 | -15.16% | 27,912株 | +206.73% | 163,134株 | +6.95% | 21,000株 | +356.52% |
2019/01/04 | 日証協 | 81,700株 | -0.12% | 9,100株 | -80.43% | 152,534株 | +0.59% | 4,600株 | -33.22% |
2018/12/28 | 日証協 | 81,800株 | +14.41% | 46,500株 | +511.84% | 151,634株 | 0% | 6,888株 | -36.81% |
2018/12/21 | 日証協 | 71,500株 | -13.86% | 7,600株 | -79.23% | 151,634株 | +16.52% | 10,900株 | -71.76% |
2018/12/14 | 日証協 | 83,000株 | +4.8% | 36,600株 | -6.63% | 130,134株 | +0.7% | 38,600株 | +135.19% |
2018/12/07 | 日証協 | 79,200株 | +0.36% | 39,200株 | +2.02% | 129,234株 | -1.82% | 16,412株 | +33.43% |
2018/11/30 | 日証協 | 78,912株 | +8.4% | 38,424株 | +154.46% | 131,634株 | -21.57% | 12,300株 | +83.58% |
2018/11/22 | 日証協 | 72,800株 | +3.41% | 15,100株 | -53.25% | 167,834株 | -30.8% | 6,700株 | -66.16% |
2018/11/16 | 日証協 | 70,400株 | +3.07% | 32,300株 | -48.57% | 242,534株 | +48.04% | 19,800株 | -83.18% |
2018/11/09 | 日証協 | 68,300株 | -8.08% | 62,800株 | +7.35% | 163,834株 | +40.71% | 117,700株 | +105.41% |
2018/11/02 | 日証協 | 74,300株 | +2.77% | 58,500株 | +83.96% | 116,434株 | -39.53% | 57,300株 | -43.38% |
2018/10/26 | 日証協 | 72,300株 | -32.62% | 31,800株 | -8.09% | 192,534株 | +52.4% | 101,200株 | +251.39% |
2018/10/19 | 日証協 | 107,300株 | -19.63% | 34,600株 | +4.85% | 126,334株 | -6.73% | 28,800株 | +3.23% |
2018/10/12 | 日証協 | 133,500株 | +4.79% | 33,000株 | +30.43% | 135,444株 | +8.32% | 27,900株 | +206.22% |
2018/10/05 | 日証協 | 127,400株 | -1.09% | 25,300株 | -16.78% | 125,044株 | +20.79% | 9,111株 | -27.11% |
※株式分割は考慮していませんのでご注意ください。
Page Top